TransMedics's three largest insider shareholders as of March 23, 2026 are Nicholas Corcoran (See Remarks, 29.83K shares), Miriam Provost (Vp, Global Regulatory Affairs, 23.35K shares), Stephen Gordon (Chief Financial Officer, 21.30K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Nicholas Corcoran | See Remarks | 29,831 | 0 | 04 Mar, 2026 |
| Miriam Provost | Vp, Global Regulatory Affairs | 23,348 | 0 | 15 Dec, 2023 |
| Stephen Gordon | Chief Financial Officer | 21,299 | 0 | 05 Jun, 2024 |
| Giovanni Cecere | Chief Commercial Officer | 19,057 | 0 | 20 Feb, 2026 |
| Gerardo Hernandez | Chief Financial Officer | 14,689 | 0 | 04 Mar, 2026 |
| John F Sullivan | Vp Of Quality Engineering | 14,273 | 0 | 01 Sep, 2021 |
| John F Carey | Vp Of Operations | 14,120 | 0 | 03 Feb, 2023 |
| Anil P. Ranganath | See Remarks | 13,091 | 0 | 04 Mar, 2026 |
| David Weill | 12,134 | 0 | 06 Mar, 2026 | |
| Laura Damme | Vp, Clinical Affairs | 5,685 | 0 | 22 Feb, 2023 |
| Thomas James Gunderson | 4,059 | 0 | 23 May, 2025 | |
| Edward M Basile | 2,866 | 0 | 31 Oct, 2025 | |
| Stephanie Lovell | 2,866 | 0 | 06 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Mar, 2026 | Stephanie Lovell | Common Stock | D | 1,193 | $149.62 | 2,866 | D | S |
| 04 Mar, 2026 | David Weill | Common Stock | A | 3,571 | $14.20 | 15,705 | D | M |
| 04 Mar, 2026 | David Weill | Common Stock | D | 3,571 | $146.82 | 12,134 | D | S |
| 04 Mar, 2026 | David Weill | Stock Option (Right to Buy) | D | 3,571 | $0.00 | 1,429 | D | M |
| 02 Mar, 2026 | Gerardo Hernandez | Common Stock | D | 375 | $139.12 | 14,689 | D | S |
| 23 Jan, 2026 | Nicholas Corcoran | Common Stock | D | 984 | $135.30 | 32,797 | D | F |
| 02 Mar, 2026 | Anil P. Ranganath | Common Stock | D | 864 | $139.12 | 13,091 | D | S |
| 04 Mar, 2026 | Gerardo Hernandez | Common Stock | A | 1,324 | $77.12 | 16,013 | D | M |
| 02 Mar, 2026 | Nicholas Corcoran | Common Stock | D | 2,966 | $139.12 | 29,831 | D | S |
| 04 Mar, 2026 | Gerardo Hernandez | Common Stock | D | 1,324 | $147.21 | 14,689 | D | S |
| 04 Mar, 2026 | Gerardo Hernandez | Common Stock | A | 5,912 | $69.84 | 20,601 | D | M |
| 04 Mar, 2026 | Gerardo Hernandez | Common Stock | D | 5,912 | $147.21 | 14,689 | D | S |
| 04 Mar, 2026 | Gerardo Hernandez | Stock Option (Right to Buy) | D | 1,324 | $0.00 | 3,975 | D | M |
| 04 Mar, 2026 | Gerardo Hernandez | Stock Option (Right to Buy) | D | 5,912 | $0.00 | 13,010 | D | M |
| 18 Feb, 2026 | Giovanni Cecere | Common Stock | A | 11,082 | $0.00 | 19,057 | D | A |
| 18 Feb, 2026 | Giovanni Cecere | Stock Option (Right to Buy) | A | 16,734 | $0.00 | 16,734 | D | A |
| 04 Dec, 2025 | Gerardo Hernandez | Common Stock | D | 920 | $139.62 | 15,064 | D | S |
| 03 Dec, 2025 | David Weill | Common Stock | A | 5,000 | $14.20 | 17,134 | D | M |
| 03 Dec, 2025 | David Weill | Common Stock | D | 5,000 | $138.64 | 12,134 | D | S |
| 03 Dec, 2025 | David Weill | Stock Option (Right to Buy) | D | 5,000 | $0.00 | 5,000 | D | M |